Year: 2019

Summit Therapeutics plc(“Summit Therapeutics” or the “Company”)Completion of $50 million Subscription and Placing and Directorate ChangesOxford, UK, and Cambridge, MA, US, 24 December 2019 – Summit Therapeutics (AIM: SUMM, NASDAQ: SMMT), a leader in antibiotic innovation, announces that the subscription and placing of new ordinary shares and warrants (the “Fundraising”) to raise approximately $50 million, which was approved by shareholders at the Company’s general meeting held on 23 December 2019, has completed. The subscription shares, comprising 166,157,050 new ordinary shares, and placing shares, comprising 9,221,400 new ordinary shares, were admitted to trading on AIM effective at 8:00 a.m. GMT on 24 December 2019.Completion of the Fundraising means that the proposed restructuring of...

PRESS RELEASE 24 DECEMBER 2019Italeaf: TerniEnergia signed the closing for the sale of 2 photovoltaic plants for a total price of Euro 0.9 millionThe sale of the last tranche of a total perimeter of 22 photovoltaic plants to Mareccio Energia, a platform for the aggregation of assets in Italy of a primary investment fund, in partnership with the sponsor LCF Alliance, through the vehicle company Italia T1 Roncolo, has been signedTotal capacity of the plants subject to closing equal to 1 MWNet collection of the fourth tranche for TerniEnergia of approximately Euro 0.4 millionTotal value of the transaction (Enterprise Value) of approximately Euro 2.7 millionThe transaction involves the assumption by the buyer of financial debts related to the plants for approximately Euro 1.8 millionThe transaction was carried out as part of the Recovery...

COMUNICATO STAMPA 24 DICEMBRE 2019Italeaf: TerniEnergia sottoscrive il closing per la cessione di 2 impianti fotovoltaici per un prezzo complessivo di Euro 0,9 milioniConclusa la cessione dell’ultima tranche di un perimetro complessivo di 22 impianti fotovoltaici a Mareccio Energia, piattaforma di aggregazione di asset in Italia di un primario fondo d’investimento, in partnership con lo sponsor LCF Alliance, attraverso la società veicolo Italia T1 RoncoloCapacità complessiva degli impianti oggetto del closing pari a circa 1 MWIncasso netto della quarta tranche per TerniEnergia pari a Euro 0,4 milioni circaControvalore complessivo dell’operazione (Enterprise Value) pari a Euro 2,7 milioni circaLa transazione prevede l’assunzione da parte dell’acquirente di debiti finanziari legati agli impianti...

CALGARY, Alberta, Dec. 24, 2019 (GLOBE NEWSWIRE) — AIM & TSX:  “TGL” & NASDAQ:  “TGA” TransGlobe Energy Corporation (“TransGlobe” or the “Company”) announces that it was notified on December 20, 2019 that on the same day Edward LaFehr and Ross Clarkson acquired common shares as follows:Notification of a Transaction pursuant to Article 19(3) of Regulation (EU) No. 596/2014About TransGlobeTransGlobe Energy Corporation is a cash-flow focused oil and gas exploration and development company whose current activities are concentrated in the Arab Republic of Egypt and Canada. TransGlobe’s common shares trade on the Toronto Stock Exchange and the AIM market of the London Stock Exchange under the symbol TGL and on the NASDAQ Exchange under the symbol TGA.(nr-reg)

IQE plc(“IQE”, the “Company” or the “Group”)2019 AGM LTIP RESOLUTION VOTING AND PROPOSED ACTIONSAt the AGM on 25 June 2019, 42.9 percent of shareholders voted against the resolution to approve the adoption of the 2019 IQE Long Term Incentive Share Option Plan (“2019 LTIP”).In line with Provision 4 of the UK Corporate Governance Code 2018, this announcement is intended to outline the Company’s understanding of the reasons behind the 2019 AGM LTIP resolution voting result and to provide an update on the actions of the Remuneration Committee and Board as a result of the vote.The 2019 LTIP replaced the previous Executive Share Option Scheme approved by shareholders at the AGM in July 2009 and was intended as a natural update to the prior rules, which had not been the subject of any representations...

Communiqué de presseLEVEE D’ENVIRON 3,9M EUROS DANS LE CADRE DE L’AUGMENTATION DE CAPITAL AVEC MAINTIEN DU DROIT PREFERENTIEL DE SOUSCRIPTION                                                                                                Levallois-Perret, le 24 décembre 2019, 08h00La société AdUX, spécialisée dans...

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONSNB Private Equity Partners Announces New Credit Facility24 December 2019NB Private Equity Partners Limited (“NBPE” or the “Company”), a closed-end private equity investment company, today announced entry into a new $200 million credit facility ($250 million inclusive of $50 million accordion) with Massachusetts Mutual Life Insurance Company (“MassMutual”) concurrent with the termination of its credit facility with JP Morgan Chase Bank, N.A. Key information and terms of the new credit facility:$200 million facility size ($250 million inclusive of $50 million accordion)Ten year borrowing availability periodInterest...

Summit Therapeutics plc (‘Summit’ or the ‘Company’)Award of Share OptionsOxford, UK, and Cambridge, MA, US, 24 December 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new mechanism antibiotic innovation, announces a grant of options over new ordinary shares of one penny nominal value (‘Ordinary Shares’) on 23 December 2019 to Mr Manmeet Soni, Dr Elaine Stracker and Dr Ventzislav Stefanov. The Company has also made a grant of share options to certain Company employees in line with the Company’s Long Term Incentive Plan.Share Option Award to Prospective Non-Executive DirectorsMr Soni, Dr Stracker and Dr Stefanov will join the Board as non-executive directors effective upon the close of the subscription and placing to raise approximately $50 million (the “Fundraising”)...